Next Article in Journal
Simultaneous Inguinal Hernia Repair with Monofilament Polypropylene Mesh during Robot-Assisted Radical Prostatectomy: Results from a Single Institute Series
Previous Article in Journal
COVID-19 and Sleep Disturbances: A Literature Review of Clinical Evidence
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Focal Segmental Glomerulosclerosis Followed by Acute Hepatitis A Infection: Case Report

1
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon 14584, Republic of Korea
2
Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon 14584, Republic of Korea
3
Department of Pathology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University School of Medicine, Bucheon 14584, Republic of Korea
*
Authors to whom correspondence should be addressed.
Medicina 2023, 59(5), 819; https://doi.org/10.3390/medicina59050819
Submission received: 16 February 2023 / Revised: 12 April 2023 / Accepted: 19 April 2023 / Published: 22 April 2023
(This article belongs to the Section Gastroenterology & Hepatology)

Abstract

:
Background and Objectives: Chronic viral hepatitis such as hepatitis B or hepatitis C is frequently related to nephropathies, yet acute hepatitis A virus (HAV) infection is an exception. Materials and Methods: A 43-year-old male presented with jaundice accompanied by nausea and vomiting. The patient was diagnosed with acute HAV infection. Although the liver function improved after conservative treatment, various symptoms such as proteinuria, hypoalbuminemia, generalized edema and pleural effusion persisted. Due to nephrotic syndrome, the patient was referred to the clinic of the nephrology department and a renal biopsy was performed. Results: The result of the renal biopsy was focal segmental glomerulosclerosis (FSGS) based on histology, electron microscopy and immunohistochemistry. Therefore, based on the clinical history and biopsy results, the patient was diagnosed as having FSGS aggravated by acute HAV infection. Proteinuria, hypoalbuminemia and generalized edema were improved after prednisolone treatment. Conclusions: Although less common, acute HAV infection can also present with an extrahepatic manifestation, for example, FSGS. Hence, clinical attention is required if proteinuria or hypoalbuminemia persists in patients with acute HAV infection.

1. Introduction

Viral hepatitis is associated with various types of extrahepatic manifestations [1]. These can occur in both acute and chronic liver diseases, and may precede or follow overt viral hepatitis [2]. However, extrahepatic manifestations of viral hepatitis are more frequently reported in chronic viral hepatitis forms such as hepatitis B virus (HBV) and hepatitis C virus (HCV) compared to hepatitis A virus (HAV) [3,4]. Specifically, there are numerous reports about glomerulonephritis following HBV or HCV infection. On the other hand, HAV is associated with acute hepatitis and does not progress to chronic hepatitis [5]. In addition, extrahepatic complications are relatively rare in HAV [1]. Although extrahepatic manifestations such as myocarditis and Guillain–Barre syndrome have been reported in acute HAV infections, there are very few reports of renal injury after HAV infection [6].
We report a case of a patient who presented with classical acute hepatitis A, whose liver profile quickly improved but who developed classical features consistent with nephrotic syndrome.

2. Case Presentation

A 43-year-old male visited a referral university hospital for jaundice and nausea. He was referred to an outpatient clinic of the gastroenterology department in a tertiary hospital due to jaundice and increased levels of liver enzymes detected during blood testing.
The patient’s medical history included dyslipidemia, fatty liver and hypothyroidism. He was taking levothyroxine, 0.05 mg daily for hypothyroidism. No medication was taken for dyslipidemia or fatty liver, and only lifestyle modification was recommended.
At the time of admission, he was 174 cm tall, weighed 74 kg and had a body mass index of 24.4 kg/m2. The blood pressure of the patient was slightly low, with a systolic blood pressure of 102 mmHg and a diastolic blood pressure of 65 mmHg. Mildly elevated body temperature (37.3 °C) and normal heart rate (78 beats per minute) with normal breathing rate (18 breaths per minute) was noted. The patient presented with nausea and jaundice, and epigastric discomfort. The patient had a soft abdomen on physical examination. Pitting edema was observed on both legs.
A liver function test at baseline was markedly elevated with mild jaundice. Levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) were 5971 U/L, 4419 U/L and 212 U/L, respectively. Prothrombin time-international normalized ratio (PT/INR) value was slightly increased to 1.62. The total bilirubin level was 2.14 mg/dL and the serum albumin level was decreased to 2.2 g/dL. Urinalysis showed proteinuria (3+) and microhematuria (3+). Spot urine total protein–creatinine ratio was 14,706. The trends of the patient’s blood tests are presented in Figure 1. The blood test results related to hepatitis virus are as follows: anti-HAV immunoglobulin M (IgM) (positive), anti-HAV immunoglobulin G (IgG) (negative), hepatitis B surface antigen (HBsAg) (negative), anti-HBs (positive), anti-HCV (negative), and anti-HEV IgM (positive). In addition, the test results for other diseases that can cause acute hepatitis other than viral hepatitis were as follows: Epstein–Barr virus (EBV) viral capsid antigen (VCA) IgM (negative), EBV VCA IgG (negative), EBV deoxyribonucleic acid (DNA) (negative), cytomegalovirus (CMV) IgM (negative), CMV IgG (negative), herpes simplex virus polymerase chain reaction (negative).
In imaging examinations, the chest X-ray showed bilateral pleural effusion (Figure 2). Contrast-enhanced abdominal computed tomography (CT) revealed mild periportal edema and subserosal edema of the gallbladder with ascites, as well as bilateral pleural effusion. Abdominal ultrasound revealed decreased echogenicity and gallbladder wall thickening, probably related to acute hepatitis.
After 8 days of supportive treatment, gastrointestinal symptoms and jaundice caused by HAV improved, liver enzyme levels markedly decreased (AST 105 U/L, ALT 218 U/L, and ALP 201 U/L) and the patient was discharged. At the time of discharge, hypoalbuminemia (serum albumin 1.7 g/dL) and general edema had not improved.
After discharge, laboratory tests were performed at an outpatient clinic for 2 months at 2-week intervals, and proteinuria and hypoalbuminemia (serum albumin 1.5 g/dL) still did not improve. In addition, pleural effusion was continuously observed on chest X-ray. The result of a 24-h urinalysis was consistent with nephrotic syndrome (urine volume 2020 mL, creatinine clearance 139.8 mL/min, total protein 14,750 mg, creatinine 1610 mg, sodium 194 mmol). Protein electrophoresis showed hypogammaglobulinemia. As a result, 2 months after discharge from the hepatology department, the patient was re-admitted to the nephrology department and a kidney biopsy was performed. On light microscopy, 14 glomeruli were contained, 2 glomeruli showed global sclerosis and other glomeruli were slightly increased in size and normocellular. Mesangial matrix was not increased, while capillary loops were somewhat wrinkled. Tubules revealed mild atrophy with interstitial fibrosis and mild mononuclear infiltration. Arteries exhibited moderate arteriosclerosis with intimal thickening (Figure 3). Eight glomeruli processed for immunofluorescence analysis showed immunoglobulin (Ig) M (1+), complement component 1q (trace) and C4 (trace), and were negative for IgG, IgA, C3, kappa and lambda (Figure 4). On electron microscopy, glomerular basement membrane was moderately irregular in contour with moderate effacement of epithelial foot processes. Some equivocal electron dense deposits were found in a subendothelial lesion (Figure 5). Overall, renal biopsy was consistent with nephrotic syndrome due to focal segmental glomerulosclerosis (FSGS). Considering both the medical history and test results, the patient was finally diagnosed with acute hepatitis A-related FSGS.
The study protocol was approved by the Institutional Review Board of Soonchunhyang University Bucheon Hospital (SCHBC 2022-12-018, date of approval 10-January-2023), and conformed to the ethical guidelines of the World Medical Association Declaration of Helsinki. Written informed consent was obtained because of the retrospective design.

3. Results

The patient started to take prednisolone 60 mg daily for 8 weeks for empirical treatment of nephrotic syndrome. The dose of prednisolone was gradually reduced every 3 weeks. After the treatment, the patient’s albumin levels were maintained within the normal range (serum albumin 4.2 g/dL), and pitting edema was also improved along with proteinuria. Random urine urinalysis showed total protein–creatinine ratio < 200. Currently, the patient is being observed in the outpatient clinic.

4. Discussion

We are reporting a case of a patient with acute hepatitis A-induced FSGS, who developed proteinuria. Referring to the previous literature review, our case is the first in the world to report a FSGS type of glomerulonephritis caused by HAV.
In chronic hepatitis B or C infection, glomerulonephritis is one of the most common extrahepatic manifestations. In particular, it has been reported that chronic hepatitis C has a higher rate of proteinuria found in urinalysis than the normal population, but the frequency of clinically serious renal disease is quite rare [7,8]. Acute tubular necrosis and acute tubulointerstitial nephritis were reported in most of the cases, and glomerular diseases such as immune complex mesangial proliferative glomerulonephritis or IgA nephropathy were rarely reported. HAV infection usually resolves spontaneously without specific treatment, but extrahepatic manifestations may occur in rare cases. Theoretically, renal injury may also occur in HAV, but much less frequently than in other types of viral hepatitis. Previous cases of renal injury caused by HAV are summarized in Table 1 [9,10,11,12,13,14,15,16,17,18,19]. IgA nephropathy was the most common renal injury caused by HAV and minimal change disease, as well as mesangial proliferation were also very common, while FSGS like our case has not been reported.
Viral infections can cause FSGS, and podocyte injury is known to be the main mechanism of FSGS [24,25]. Viral infections that can cause FSGS include human immunodeficiency virus (HIV), Parvovirus B19, HBV and HCV. In HIV, the main pathophysiology of FSGS is the expression of HIV transgenes in podocytes, dedifferentiation and apoptosis of podocytes caused by apolipoprotein L1 variant transcription and accumulation of immune complex in glomerular capillaries [26,27]. Parvovirus B19-associated FSGS exhibits a loss of differentiation and a gain of proliferation in podocytes [28]. In HBV-associated FSGS, the virus may have a direct pathogenic effect, as HBV-DNA was found in urinary podocytes using real-time polymerase chain reaction [29]. The mechanism of HCV-associated FSGS is not clear, but it may be caused by direct podocyte injury similar to HIV [29].
On the other hand, unlike other viruses, the mechanism by which HAV causes kidney injury is unclear. Hepatitis A antigen was found in renal glomeruli in marmosets, but has not yet been found in humans [30]. HAV infects using T cell immunoglobulin mucin domain 1 (TIM1), known as kidney injury molecule 1 (KIM1), which can be highly expressed by renal cells. KIM1 is a type I transmembrane protein with an immunoglobulin and mucin domain whose expression is markedly upregulated in the proximal tubule cells [31,32]. However, HAV has not been detected in renal tissue [10]. Thus, further research is needed to understand why HAV caused direct podocyte injury, as in our case.
Since most cases of HAV recover without complications and extrahepatic manifestations are very rare, clinicians tend not to actively evaluate organs other than the liver. Especially, hepatitis A rarely manifests with nephrotic syndrome [33]. However, since nephrotic syndrome does occur in some cases such as ours, clinicians should pay attention. The clinical definition of adult nephrotic syndrome includes massive proteinuria (≥3.5 g/day), hypoalbuminemia (serum albumin ≤ 3.0 g/dL), edema and dyslipidemia (hyper-LDL cholesterol). The predominant symptom of nephrotic syndrome is edema, and also, in our case, pretibial edema was observed from the time of admission. Looking at the existing cases of HAV-induced renal injury (Table 1), proteinuria was present in eight out of nine cases (88.9%) including our case. In laboratory findings, hematological abnormalities such as hypoalbuminemia, hypercholesterolemia, renal and liver dysfunction, electrolyte disorders, coagulation/fibrinolysis disorders, hormonal disorders and anemia are usually found in patients with nephrotic syndrome [34]. Clinically, nephrotic syndrome should be suspected when the above symptoms are present, especially proteinuria and edema. Renal biopsy is usually considered useful and recommended for definitive diagnosis. In fact, renal biopsy was performed in all nine existing cases (Table 1). Table 1 shows that acute hepatitis A cases reported in Korea are concentrated in a specific age group (27–43 years). Regarding the high incidence of acute HAV in a specific age group, the Korean government has included the hepatitis A vaccine in the national mandatory vaccination program for newborns born after January 2012. Until then, it was not a mandatory vaccine. Therefore, in Korea, the current rate of antibody positivity for hepatitis A is low among people in their 20s and 40s. In 2015, the antibody positivity rate for Koreans in their 20s and 30s was only 12.6% and 31.8%, respectively. Because of this phenomenon, it seems that the ages of HAV patients in Korea are concentrated between 27–43 years old.
In our case report, it’s important to note that the patient had low levels of albumin and pleural effusion from the start of their hospitalization. It is known that hypoalbuminemia can lead to pleural effusion, so when doctors notice effusions in patients with low albumin levels, they should investigate other possible causes with thorough clinical evaluations [35,36]. Although the rate of pleural effusion may vary depending on the underlying condition or disease that caused the hypoalbuminemia, it is estimated that up to 90% of patients with nephrotic syndrome have hypoalbuminemia [37,38]. Thus, if a patient with acute hepatitis rapidly improves, but hypalbuminemia persists and edema develops, causes of renal protein loss and renal disease should be incorporated in the differential diagnosis.
Treatment should be individualized for each patient. In six out of nine cases (66.7%), renal injury was improved only with supportive treatment, which seems to be related to the pathology of renal injury. Most cases of IgA nephropathy, minimal change disease and mesangial proliferation have a good prognosis. However, in the case of interstitial nephritis or FSGS as in this case, active treatment such as steroid treatment and dialysis is required. Regarding our case, about half of the cases of FSGS are non-responders to steroid treatment. The responsive rate and renal prognosis vary across the variant types of FSGS. In the tip variant, steroid response was present in 97% and the remission rate was 75%, being the highest among FSGS and the progression rate to end-stage renal disease was 5.7% [33]. For the treatment of secondary FSGS, the priority is to treat the underlying disease [39,40,41]. However, if nephrotic syndrome persists even after the causative disease has improved, as in the idiopathic nephrotic syndrome treatment, steroid therapy should be considered first, followed by immunosuppressive therapy according to steroid dependence/resistance [34].

5. Conclusions

In conclusion, although not common, renal injury may occur as one of the complications of HAV infection. Therefore, hepatitis A patients with edema, proteinuria and hypoalbuminemia require special clinical attention. Further research on the mechanism of why HAV causes such FSGS is needed.

Author Contributions

Conceptualization, J.-J.Y.; methodology, J.K.K.; formal analysis, J.-J.Y.; investigation, J.K.K.; resources, M.-W.A.; data curation, M.-W.A.; writing—original draft preparation, M.-W.A.; writing—review and editing, J.-J.Y.; visualization, M.-W.A.; supervision, J.K.K.; project administration, S.G.K. and Y.S.K. Pathological findings description: A.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2021R1G1A1007886), and in part by the Soonchunhyang University Research Fund (2023).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Soonchunhyang University Bucheon Hospital (SCHBC 2022-12-018, date of approval 10-January-2023).

Informed Consent Statement

Patient consent was waived due to the retrospective nature of this case report.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Amarapurkar, D.N.; Amarapurkar, A.D. Extrahepatic manifestations of viral hepatitis. Ann. Hepatol. 2002, 1, 192–195. [Google Scholar] [CrossRef]
  2. Jang, W.; Lee, H.W.; Lee, J.S.; Kim, B.K.; Kim, S.U.; Park, J.Y.; Ahn, S.H.; Kim, D.Y. Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology. J. Liver Cancer 2022, 22, 158–166. [Google Scholar] [CrossRef]
  3. Pyrsopoulos, N.T.; Reddy, K.R. Extrahepatic manifestations of chronic viral hepatitis. Curr. Gastroenterol. Rep. 2001, 3, 71–78. [Google Scholar] [CrossRef] [PubMed]
  4. Lee, H.W. Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma? J. Liver Cancer 2022, 22, 91–92. [Google Scholar] [CrossRef]
  5. Shin, E.C.; Jeong, S.H. Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis A. Cold Spring Harb. Perspect. Med. 2018, 8, a031708. [Google Scholar] [CrossRef]
  6. Menon, D.; Jagtap, S.A.; Nair, M.D. Guillain-Barre syndrome following acute viral hepatitis A. J. Neurosci. Rural Pract. 2014, 5, 204–205. [Google Scholar] [CrossRef]
  7. Huang, J.F.; Chuang, W.L.; Dai, C.Y.; Ho, C.K.; Hwang, S.J.; Chen, S.C.; Lin, Z.Y.; Wang, L.Y.; Chang, W.Y.; Yu, M.L. Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: Another chain of link? J. Intern. Med. 2006, 260, 255–262. [Google Scholar] [CrossRef]
  8. Barsoum, R.S.; William, E.A.; Khalil, S.S. Hepatitis C and kidney disease: A narrative review. J. Adv. Res. 2017, 8, 113–130. [Google Scholar] [CrossRef]
  9. Abutaleb, A.; Kottilil, S. Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention. Gastroenterol. Clin. N. Am. 2020, 49, 191–199. [Google Scholar] [CrossRef] [PubMed]
  10. Andrievskaya, M.; Lenhart, A.; Uduman, J. Emerging Threat: Changing Epidemiology of Hepatitis A and Acute Kidney Injury. Adv. Chronic Kidney Dis. 2019, 26, 171–178. [Google Scholar] [CrossRef] [PubMed]
  11. Morita, M.; Kitajima, K.; Yoshizawa, H.; Itoh, Y.; Iwakiri, S.; Shibata, C.; Mayumi, M. Glomerulonephritis associated with arteritis in marmosets infected with hepatitis A virus. Br. J. Exp. Pathol. 1981, 62, 103–113. [Google Scholar] [PubMed]
  12. Han, S.H.; Kang, E.W.; Kie, J.H.; Yoo, T.H.; Choi, K.H.; Han, D.S.; Kang, S.W. Spontaneous remission of IgA nephropathy associated with resolution of hepatitis A. Am. J. Kidney. Dis. 2010, 56, 1163–1167. [Google Scholar] [CrossRef]
  13. Cho, E.; Cha, I.; Yoon, K.; Yang, H.N.; Kim, H.W.; Kim, M.G.; Jo, S.K.; Cho, W.Y.; Kim, H.K. Hemophagocytic syndrome in a patient with acute tubulointerstitial nephritis secondary to hepatitis A virus infection. J. Korean Med. Sci. 2010, 25, 1529–1531. [Google Scholar] [CrossRef]
  14. Aggarwal, A.; Kumar, D.; Kumar, R. Acute glomerulonephritis in hepatitis A virus infection: A rare presentation. Trop. Dr. 2009, 39, 186–187. [Google Scholar] [CrossRef] [PubMed]
  15. Kim, S.H.; Yoon, H.E.; Kim, Y.K.; Kim, J.Y.; Choi, B.S.; Choi, Y.J.; Kim, Y.O.; Kim, Y.S.; Bang, B.K.; Yang, C.W. Acute hepatitis A-associated acute renal failure in adults. Nephron Clin. Pract. 2008, 109, c127–c132. [Google Scholar] [CrossRef] [PubMed]
  16. Ono, S.; Fujishiro, M.; Kodashima, S.; Minatsuki, C.; Hirano, K.; Niimi, K.; Goto, O.; Yamamichi, N.; Fukuda, T.; Seto, Y.; et al. High-dose dexamethasone may prevent esophageal stricture after endoscopic submucosal dissection. Clin. J. Gastroenterol. 2010, 3, 155–158. [Google Scholar] [CrossRef]
  17. Zikos, D.; Grewal, K.S.; Craig, K.; Cheng, J.C.; Peterson, D.R.; Fisher, K.A. Nephrotic syndrome and acute renal failure associated with hepatitis A virus infection. Am. J. Gastroenterol. 1995, 90, 295–298. [Google Scholar] [PubMed]
  18. Mathur, R.C.; Mathur, N.C. Mesangial proliferative glomerulonephritis and nephrotic syndrome with hepatitis A virus infection. Indian Pediatr. 1996, 33, 1051–1053. [Google Scholar]
  19. Pal, R.B.; Saha, P.; Das, I.; Sinha, M.K. Fulminant hepatitis and glomerulonephritis--a rare presentation of hepatitis A virus infection. Acta Paediatr. 2011, 100, e132–e134. [Google Scholar] [CrossRef]
  20. LEE, S.-M.; KIM, B.-S.; PARK, G.-W.; LIM, M.-K.; MAENG, L.-S.; LEE, S.-H.; CHANG, Y.-S. A case of acute renal failure and IgA nephropathy associated with acute hepatitis A. Korean J. Med. 2004, 67, 804–808. [Google Scholar]
  21. HAN, S.-S.; KIM, M.-K.; Choi, B.-Y.; Min, H.-S.; Kim, H.-L.; Lim, C.-S.; Lee, H.-J.; Moon, K.-C.; Oh, Y.-K. Interstitial Nephritis and IgA Nephropathy in a Patient with Acute Hepatitis A. Korean J. Nephrol. 2007, 26, 748–752. [Google Scholar]
  22. Kron, M.A.; Hedger, R. Hepatitis A-induced remission of minimal change nephropathy. Arch. Intern. Med. 1984, 144, 2279–2280. [Google Scholar] [CrossRef] [PubMed]
  23. Demircin, G.; Oner, A.; Tinaztepe, K.; Bulbul, M.; Demiriz, M.; Erdogan, O. Acute glomerulonephritis in hepatitis A virus infection. J. Pediatr. Gastroenterol. Nutr. 1998, 27, 86–89. [Google Scholar] [CrossRef]
  24. Wen, Y.; Shah, S.; Campbell, K.N. Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis. Front. Med. 2018, 5, 98. [Google Scholar] [CrossRef] [PubMed]
  25. Reidy, K.; Kaskel, F.J. Pathophysiology of focal segmental glomerulosclerosis. Pediatr. Nephrol. 2007, 22, 350–354. [Google Scholar] [CrossRef]
  26. Wyatt, C.M.; Klotman, P.E.; D’Agati, V.D. HIV-associated nephropathy: Clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin. Nephrol. 2008, 28, 513–522. [Google Scholar] [CrossRef]
  27. Medapalli, R.K.; He, J.C.; Klotman, P.E. HIV-associated nephropathy: Pathogenesis. Curr. Opin. Nephrol. Hypertens. 2011, 20, 306–311. [Google Scholar] [CrossRef]
  28. Sanchez, C.; Fenves, A.; Schwartz, J. Focal segmental glomerulosclerosis and parvovirus B19. Proc. (Bayl. Univ. Med. Cent.) 2012, 25, 20–22. [Google Scholar] [CrossRef]
  29. Gupta, A.; Quigg, R.J. Glomerular Diseases Associated With Hepatitis B and C. Adv. Chronic Kidney Dis. 2015, 22, 343–351. [Google Scholar] [CrossRef] [PubMed]
  30. Mathiesen, L.R.; Drucker, J.; Lorenz, D.; Wagner, J.A.; Gerety, R.J.; Purcell, R.H. Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus. J. Infect. Dis. 1978, 138, 369–377. [Google Scholar] [CrossRef]
  31. Han, W.K.; Bailly, V.; Abichandani, R.; Thadhani, R.; Bonventre, J.V. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002, 62, 237–244. [Google Scholar] [CrossRef]
  32. Freeman, G.J.; Casasnovas, J.M.; Umetsu, D.T.; DeKruyff, R.H. TIM genes: A family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol. Rev. 2010, 235, 172–189. [Google Scholar] [CrossRef]
  33. Stokes, M.B.; Valeri, A.M.; Markowitz, G.S.; D’Agati, V.D. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int. 2006, 70, 1783–1792. [Google Scholar] [CrossRef] [PubMed]
  34. Nishi, S.; Ubara, Y.; Utsunomiya, Y.; Okada, K.; Obata, Y.; Kai, H.; Kiyomoto, H.; Goto, S.; Konta, T.; Sasatomi, Y.; et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin. Exp. Nephrol. 2016, 20, 342–370. [Google Scholar] [CrossRef] [PubMed]
  35. Puchalski, J.T.; Argento, A.C.; Murphy, T.E.; Araujo, K.L.; Oliva, I.B.; Rubinowitz, A.N.; Pisani, M.A. Etiologies of bilateral pleural effusions. Respir. Med. 2013, 107, 284–291. [Google Scholar] [CrossRef]
  36. Mattison, L.E.; Coppage, L.; Alderman, D.F.; Herlong, J.O.; Sahn, S.A. Pleural effusions in the medical ICU: Prevalence, causes, and clinical implications. Chest 1997, 111, 1018–1023. [Google Scholar] [CrossRef] [PubMed]
  37. Kodner, C. Diagnosis and Management of Nephrotic Syndrome in Adults. Am. Fam. Physician 2016, 93, 479–485. [Google Scholar]
  38. Politano, S.A.; Colbert, G.B.; Hamiduzzaman, N. Nephrotic Syndrome. Prim. Care 2020, 47, 597–613. [Google Scholar] [CrossRef]
  39. Rosenberg, A.Z.; Kopp, J.B. Focal Segmental Glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 2017, 12, 502–517. [Google Scholar] [CrossRef] [PubMed]
  40. Zheng, X.Y.; Wei, R.B.; Tang, L.; Li, P.; Zheng, X.D. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J. Gastroenterol. 2012, 18, 821–832. [Google Scholar] [CrossRef] [PubMed]
  41. Li, C.; Li, H.; Su, W.; Wen, Y.B.; Ye, W.; Ye, W.L.; Cai, J.F.; Qin, X.Z.; Li, X.M.; Li, X.W. Clinicopathological study of mixed cryoglobulinemic glomerulonephritis secondary to hepatitis B virus infection. BMC Nephrol. 2020, 21, 395. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Clinical course of the patient.
Figure 1. Clinical course of the patient.
Medicina 59 00819 g001
Figure 2. Chest X-ray of the patient showing pleural effusion.
Figure 2. Chest X-ray of the patient showing pleural effusion.
Medicina 59 00819 g002
Figure 3. Results of renal biopsy, light microscopy (A) PAS staining, ×200, (B) Silver staining, ×200. Segmental glomerulosclerosis, lower right glomerulus (arrow). An adhesion is identified. The adhesion had a cell bridging between the laminated Bowman’s capsule and the glomerular basement membrane. It is suitable for the FSGS tip variant. The presence of Bowman capsule reaction helps distinguish a real adhesion from an artifact.
Figure 3. Results of renal biopsy, light microscopy (A) PAS staining, ×200, (B) Silver staining, ×200. Segmental glomerulosclerosis, lower right glomerulus (arrow). An adhesion is identified. The adhesion had a cell bridging between the laminated Bowman’s capsule and the glomerular basement membrane. It is suitable for the FSGS tip variant. The presence of Bowman capsule reaction helps distinguish a real adhesion from an artifact.
Medicina 59 00819 g003
Figure 4. Results of renal biopsy, immunofluorescence IgM by immunofluorescence showed a mild positive (1+).
Figure 4. Results of renal biopsy, immunofluorescence IgM by immunofluorescence showed a mild positive (1+).
Medicina 59 00819 g004
Figure 5. Results of renal biopsy, electron microscopy. Extensive foot process effacement accompanied by glomerular basement membrane wrinkling is seen.
Figure 5. Results of renal biopsy, electron microscopy. Extensive foot process effacement accompanied by glomerular basement membrane wrinkling is seen.
Medicina 59 00819 g005
Table 1. Characteristics of HAV-associated glomerular diseases based on prior case reports.
Table 1. Characteristics of HAV-associated glomerular diseases based on prior case reports.
Case Report DemographicsCourse of IllnessInitial Values
LocationSexAge (yr)SymptomBiopsy TreatmentOutcomeAST/ALT
(U/L)
Albumin
(g/dL)
Proteinuria
Our caseRep. of KoreaM43Jaundice, Nausea Focal segmental glomerulosclerosisPrednisoloneImproved5971/44192.2Presence
Han et al., 2010 [12]Rep. of KoreaF30General weaknessIgA nephropathyLosartanImproved1917/29441.1Presence
Hong et al., 2010 [13] Rep. of KoreaF30General weaknessIgA nephropathySupportiveImproved1917/29441.1Presence
Lee et al., 2004 [20] Rep. of KoreaM27AnorexiaIgA nephropathySupportiveImproved388/1566NormalTrace
Han et al., 2007 [21]Rep. of KoreaF31Fever, myalgiaIgA nephropathy
and Interstitial nephritis
HemodialysisImproved17,215/6874NormalPresence
Kron et al., 1984 [22]USAM5Asymptomatic proteinuriaMinimal change diseaseSupportiveImproved70/NANormalPresence
Pal et al., 2011 [19]IndiaM3JaundiceMesangial proliferationSupportiveImproved4695/3836NormalPresence
Demircin et al., 1998 [23]TurkeyM7Jaundice, dyspneaMesangial proliferationSupportiveImproved65/62NormalPresence
Demircin et al., 1998 [23]TurkeyM6Jaundice, dyspneaMesangial proliferationSupportiveImproved70/86NormalPresence
Abbreviations: HAV, hepatitis A virus; yr, year; NA, non-available.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

An, M.-W.; Yoo, J.-J.; Kim, J.K.; Moon, A.; Kim, S.G.; Kim, Y.S. Focal Segmental Glomerulosclerosis Followed by Acute Hepatitis A Infection: Case Report. Medicina 2023, 59, 819. https://doi.org/10.3390/medicina59050819

AMA Style

An M-W, Yoo J-J, Kim JK, Moon A, Kim SG, Kim YS. Focal Segmental Glomerulosclerosis Followed by Acute Hepatitis A Infection: Case Report. Medicina. 2023; 59(5):819. https://doi.org/10.3390/medicina59050819

Chicago/Turabian Style

An, Min-Woo, Jeong-Ju Yoo, Jin Kuk Kim, Ahrim Moon, Sang Gyune Kim, and Young Seok Kim. 2023. "Focal Segmental Glomerulosclerosis Followed by Acute Hepatitis A Infection: Case Report" Medicina 59, no. 5: 819. https://doi.org/10.3390/medicina59050819

Article Metrics

Back to TopTop